Protocol Tip of the Week
If you're stacking NAD+ precursors for muscle preservation, stop treating them as a monotherapy — the sarcopenia data this week shows precursors only move the needle when paired with adequate dietary nucleotide/protein intake. And if you're serious about gut-driven metabolic aging, start paying attention to bile acid profiles, not just your microbiome diversity score — composition without function is a vanity metric.Study 1: Your Gut Bacteria Are Quietly Sabotaging Your Metabolism as You Age
(PMID: 43038987)Researchers found that aging guts lose the microbial capacity to deconjugate bile acids — a process that normally helps regulate lipid metabolism, insulin sensitivity, and inflammatory tone. As this bacterial function declines, metabolic health craters in parallel, and the paper shows this isn't just correlation: restoring deconjugation capacity in aged models countered metabolic decline directly. This is a mechanistic paper, not just another "microbiome diversity matters" hand-wave.
Why this matters: bile acids aren't just digestive leftovers, they're signaling molecules that talk to FXR and TGR5 receptors controlling glucose and lipid handling. If your gut bacteria can't deconjugate them anymore, you lose a whole layer of metabolic regulation — and this probably explains part of why insulin resistance creeps up with age even in people who haven't changed their diet.
The practical angle is still immature — this isn't "take this probiotic" territory yet — but it reframes where to look. Fiber-fermenting, bile-acid-active bacteria (think Clostridia clusters, not just Lactobacillus) deserve more attention than they're getting in the consumer probiotic space. If you're optimizing gut health for metabolic longevity, functional output (bile acid profiles via stool or serum testing) is a smarter target than 16S diversity scores. Expect this pathway to become a drug target faster than a lifestyle one — FXR agonists are already in development pipelines elsewhere.
Study 2: Eating the Same 5 Foods Every Day Is Quietly Aging You Faster
(PMID: 43032136)This 10-year multistate analysis of the Chinese Longitudinal Healthy Longevity Survey tracked frailty transitions in older adults based on dietary diversity — essentially, how many different food groups people regularly consumed. Higher dietary diversity was associated with slower transitions into frailty states and longer "frailty-free" life expectancy. This is a large, long-duration cohort, which gives it real weight, even though it's observational (correlation, not causation — can't fully rule out reverse causality, since healthier people may simply have more resources/motivation to eat diverse diets).
The actionable signal here isn't "eat more polyphenols" or chase some trendy macro ratio — it's dietary variety itself, independent of any single nutrient. This tracks with what we already know about microbiome resilience and nutrient redundancy: a diet built on 20 rotating whole foods is going to buffer against deficiency and metabolic rigidity far better than one built on 5 "optimized" staples, no matter how biohacked those staples are.
Our take: this is a useful counterweight to the reductionist tendency in this space to obsess over single compounds (resveratrol, spermidine, whatever). Frailty isn't a supplement-deficiency disease — it's a systems resilience problem, and dietary diversity is a crude but real proxy for nutritional systems resilience. If you're over 60 and your diet looks the same every day, that's a bigger problem than your NAD+ levels.
Study 3: Four Blood Proteins May Predict Who Ages Well — Across Generations
(PMID: 43025377)This study identified four plasma proteins — GSN (gelsolin), F2 (prothrombin), CRTAC1, and HP (haptoglobin) — associated with longevity and resilience, and critically, these associations held across generations within long-lived families. That multigenerational angle is the interesting part: it suggests these aren't just markers of "being old," but markers tied to heritable resilience phenotypes that show up even in middle-aged relatives of long-lived people.
Gelsolin in particular has been floated before in sepsis/trauma resilience literature as a actin-scavenging protein that modulates inflammation; prothrombin and haptoglobin tie into coagulation and oxidative stress buffering respectively. The fact that this panel clusters together across generations gives it more credibility as a genuine resilience signature rather than a random biomarker fishing expedition.
The catch: this is association work in an EBioMedicine paper, and panels like this have a long history of looking great in discovery cohorts and then not replicating or not being actionable. There's no intervention data here — nobody's shown that raising gelsolin does anything useful. File this under "watch, don't act." If a commercial biological age test starts touting "GSN levels" in six months, be skeptical until independent replication and interventional studies exist.
Study 4: NAD+ Precursors Won't Fix Your Sarcopenia If You're Nucleotide-Deficient
(PMID: 43040062)This review/study examines dietary nucleotides alongside NAD+ precursors (NMN, NR, etc.) in the context of age-related muscle loss. The core argument: sarcopenia isn't purely an NAD+ depletion problem — it's also a substrate availability problem, where aging guts and diets often fail to supply enough dietary nucleotides needed for cellular turnover, immune function, and tissue repair in skeletal muscle.
This matters because the NAD+ supplement industry has largely sold a one-variable story: boost NAD+, fix mitochondrial function, save your muscles. This paper pushes back on that simplicity by pointing out that NAD+ precursor supplementation without adequate nucleotide/protein substrate may underperform — you can have all the NAD+ precursor in the world and still lack the raw materials for muscle protein synthesis and repair machinery.
Our opinionated take: this is a useful corrective, not a reason to abandon NR/NMN protocols. But it reinforces something we've said before — NAD+ supplementation is not a replacement for basic nutritional fundamentals (adequate protein, resistance training, and yes, apparently dietary nucleotide-rich foods like organ meats and certain legumes). If your sarcopenia protocol is "NMN and vibes," you're missing half the equation. Pair any NAD+ strategy with resistance training and real food-based nucleotide/protein intake, or you're optimizing a pathway your body can't use.